TPG GP A’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21.1M | Hold |
18,716,306
| – | – | 1.13% | 8 |
|
2025
Q1 | $27.3M | Hold |
18,716,306
| – | – | 0.54% | 26 |
|
2024
Q4 | $39.9M | Hold |
18,716,306
| – | – | 0.64% | 29 |
|
2024
Q3 | $52.4M | Hold |
18,716,306
| – | – | 0.89% | 23 |
|
2024
Q2 | $43.6M | Hold |
18,716,306
| – | – | 0.68% | 27 |
|
2024
Q1 | $83.7M | Hold |
18,716,306
| – | – | 1.6% | 18 |
|
2023
Q4 | $60.1M | Hold |
18,716,306
| – | – | 0.97% | 26 |
|
2023
Q3 | $59.3M | Hold |
18,716,306
| – | – | 1.02% | 23 |
|
2023
Q2 | $93M | Hold |
18,716,306
| – | – | 1.37% | 19 |
|
2023
Q1 | $92.5M | Hold |
18,716,306
| – | – | 1.51% | 19 |
|
2022
Q4 | $118M | Hold |
18,716,306
| – | – | 2.31% | 16 |
|
2022
Q3 | $202M | Hold |
18,716,306
| – | – | 3.31% | 12 |
|
2022
Q2 | $213M | Hold |
18,716,306
| – | – | 3.3% | 11 |
|
2022
Q1 | $171M | Hold |
18,716,306
| – | – | 2.11% | 14 |
|
2021
Q4 | $279M | Buy |
+18,716,306
| New | +$279M | 2.79% | 10 |
|